Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / SHS
-
Number of holders
-
234
-
Total 13F shares, excl. options
-
150M
-
Shares change
-
-1.71M
-
Total reported value, excl. options
-
$2.94B
-
Value change
-
-$32.9M
-
Put/Call ratio
-
0.57
-
Number of buys
-
126
-
Number of sells
-
-102
-
Price
-
$19.54
Significant Holders of HORIZON PHARMA PLC - SHS (HZNP) as of Q4 2018
285 filings reported holding HZNP - HORIZON PHARMA PLC - SHS as of Q4 2018.
HORIZON PHARMA PLC - SHS (HZNP) has 234 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 150M shares
.
Largest 10 shareholders include Vanguard Group Inc (15.4M shares), BlackRock Inc. (13.9M shares), SCOPIA CAPITAL MANAGEMENT LP (10.7M shares), PAULSON & CO. INC. (7.17M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (6.83M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (6.67M shares), RENAISSANCE TECHNOLOGIES LLC (6.07M shares), JPMORGAN CHASE & CO (5.2M shares), DIMENSIONAL FUND ADVISORS LP (5.14M shares), and venBio Select Advisor LLC (4.35M shares).
This table shows the top 234 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.